KATHRYN BRYANT: Open Payments
NPI 1811397177 · PETALUMA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$83 in 3 payments from 3 companies in 2025. Trend: 2023 $367 · 2024 $0 · 2025 $83
Food & beverage: $83
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
Products named: REXULTI, Veozah, GEMTESA.
Industry payments across CA — which companies pay providers there.
